Prodrugs of 5,5-diphenylhydantoin as antiepileptic and antiarrhythmic agents

摘要

The present invention deals with a product with the formula (I) which is a new prodrug of phenytoin, as well as its therapeutically acceptable solvates and addition salts. This product shows a solubility significantly higher than phenytoin itself. In addition, surprisingly, its hydrolisis rate is far higher than that of other known prodrugs of phenytoin, making it particularly useful as antiepileptic and antiarrhythmic agent.